WebJul 12, 2024 · Breast cancer is the most common disease and the leading cause of cancer-associated mortality in women worldwide . At present, several strategies are employed for the treatment of early breast cancer, ... KLF5, a downstream protein of YAP, had the lowest expression in the UM+SIM group (Fig. 4A). WebExpression of KLF5 (BTEB2, CKLF, IKLF) in cancer tissue. The cancer tissue page shows antibody staining of the protein in 20 different cancers.
Targeting the KLF5-EphA2 axis can restrain cancer
WebFigure 8.1. Relationships between steroid hormones and KLF5 in breast cells. ① Estrogen and ERα induce the expression of the EFP E3 ubiquitin ligase, which targets KLF5 for degradation in ERα-positive breast cancer cells. ② KLF5 interacts with ERα to suppress ERα-mediated transcription of c-Myc and CSTD in ERα-positive breast cancer cells. ③ … WebIn breast cancer, KLF5 promotes cancer cell proliferation and the cell cycle by inducing transcription of FGF-BP1, 25 mPGES1, 26 TNFAIP2, 27 and Cyclin D1 4 and inhibiting transcription of p27 5 and p21. 26 KLF5 maintains cell stemness by inducing the transcription of Slug 7 and Nanog. 6 KLF5 is essential for progesterone to induce cell ... ether melting and boiling point
Breast cancer metastasis suppressor 1 gene - National Library of ...
WebApr 24, 2024 · Triple negative breast cancer (TNBC) is one of the most aggressive breast cancers without effective targeted therapies. Numerous studies have implied that KLF5 plays an important roles in TNBC. How is KLF5 regulated by microRNAs has not been well studied. Here, we demonstrated that miR-217 down-regulates the expression of KLF5 … WebThe long noncoding RNA (lncRNA) LINC00152, also known as CYTOR, displays aberrant expression in various cancers. However, its clinical value and functional mechanisms in breast cancer remain insufficiently understood. Our study found that LINC00152 is significantly upregulated in breast cancer, and that it acts as an indicator of poor … WebMar 19, 2024 · Breast cancer, cervical cancer, hepatocellular carcinoma, and bladder cancer are all aided by KLF5 [29–31]. Furthermore, KLF5 expression has been linked to a poor prognosis in lung cancer, and in vitro tests have shown that a decrease of KLF5 may overcome cisplatin resistance in lung cancer [ 32 ]. ether metabolism